Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by mcarter4on Nov 27, 2003 4:16pm
278 Views
Post# 6708643

RE: Hey , you bunch of sniveling cowards!!!:BW

RE: Hey , you bunch of sniveling cowards!!!:BWTo each their own I guess. This a message board and as a long I have the right to express my opinions. I guess I have higher standards of a well compensated CEO. Bewilderment at regulatory agencies, confusion on accounting and reporting standards, only expressed annoyance at the slower-than-syrup-running-up-hill in January lead investigator, and continually delayed trial results just don't quite cut it for me. He developed the BPlan it seems appropriate to expect objectives to be met. However, on the positive side the science seems sound. Tell you what I'd be willing to do, on the next ONC quarterly CC (I think I missed the last one or was there even one). If ONC mngt. opened up the Q&A to all investors I would gladly ask a number of specific questions re. performance. I've done it before and would gladly do it here. I prefer not to go the email/telephone route as you always get back the party line, which is generally well known. Now as far as the other stuff you posted it seems a bit childish, but again to each their own.
Bullboard Posts